Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of plantar warts located on the bottom of the foot. Plantar warts are characterized by their specific location, tenderness, and disruption of the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and if necessary, the wart may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

If the size of the wart requires it, the medicated patch can be cut to fit the wart appropriately. The medicated patch should then be carefully adhered directly over the wart. To ensure proper coverage and concealment, the medicated patch should be covered with a pad.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated, infected, or reddened skin is prohibited due to the potential for exacerbation of the condition. The product should not be applied to genital warts or warts located on the face, as these areas may be sensitive and require specialized treatment. Additionally, the use of this product on moles, birthmarks, or warts with hair growing from them is contraindicated to avoid complications.

The product is also contraindicated for use on mucous membranes, as this may lead to irritation or adverse reactions. Patients with diabetes should not use this product due to the risk of impaired healing and potential complications. Furthermore, individuals with poor blood circulation are advised against using this product, as it may exacerbate their condition.

Warnings and Precautions

For external use only. This product is contraindicated in several specific situations. It should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, application to mucous membranes is prohibited.

Patients with diabetes or those who have poor blood circulation should avoid using this product due to the increased risk of adverse effects.

If discomfort persists after application, it is imperative to discontinue use and consult a healthcare professional for further evaluation and guidance.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, the product should not be applied to mucous membranes and is not recommended for individuals who are diabetic or have poor blood circulation.

In the event that discomfort persists after application, patients are advised to discontinue use and consult a healthcare professional. It is crucial to keep this product out of reach of children. If swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (medicated plantar wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in the absence of established safety information. Women of childbearing potential should be counseled on the importance of effective contraception while using this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the medication should not be applied to irritated, infected, or reddened skin. It is also important to emphasize that the medication is not intended for use on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be cautioned against using the medication on mucous membranes.

Healthcare providers should discuss the contraindications associated with the medication, specifically advising patients not to use it if they are diabetic or have poor blood circulation. Patients should be instructed to discontinue use and consult a doctor if discomfort persists.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 15° to 30°C (59° to 86°F) to maintain its efficacy and stability. Proper storage conditions should be observed to ensure the integrity of the product throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)